Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $32.75 USD
Change Today -0.75 / -2.24%
Volume 819.3K
SRPT On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 08/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Patrick L. Iversen Ph.D.

Former Senior Vice President of Research & Innovation, Sarepta Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

59--

Background*

Dr. Patrick L. Iversen, Ph.D. has been Senior Vice President of Research and Innovation at AVI Biopharma, Inc. since October 2010. In this position, Dr. Iversen has expanded responsibility for the identification and advancement of new drug discovery initiatives and the development of novel therapeutic applications of AVI's RNA-based technology. Over the last 21 years, he has been a leading innovator in the research and development of RNA-based therapeutics. He served ...

Read Full Background

Corporate Headquarters*

215 First Street
Cambridge, Massachusetts 02142

United States

Phone: 617-274-4000
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
The University of Utah
BS
Westminster College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SRPT:US $32.75 USD -0.75

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ron Cohen M.D.Founder, Chief Executive Officer, President and Director
Acorda Therapeutics, Inc.
$745.8K
Edward M. Kaye M.D., Ph.D.Interim Chief Executive Officer, Chief Medical Officer and Senior Vice President
Sarepta Therapeutics, Inc.
$399.0K
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$620.1K
Stephen R. Davis J.D.Interim Chief Executive Officer, Chief Financial Officer, Chief Business Officer and Executive Vice President
ACADIA Pharmaceuticals Inc.
$245.6K
John M. Maraganore M.D., Ph.D.Chief Executive Officer and Executive Director
Alnylam Pharmaceuticals, Inc.
$689.6K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SAREPTA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.